FMC (FMC) Reports Next Week: Wall Street Expects Earnings Growth
Werte in diesem Artikel
Wall Street expects a year-over-year increase in earnings on higher revenues when FMC (FMC) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 29. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.Zacks Consensus EstimateThis chemical producer is expected to post quarterly earnings of $0.49 per share in its upcoming report, which represents a year-over-year change of +11.4%.Revenues are expected to be $1.04 billion, up 5.4% from the year-ago quarter.Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.7% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).How Have the Numbers Shaped Up for FMC?For FMC, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.69%.On the other hand, the stock currently carries a Zacks Rank of #4.So, this combination makes it difficult to conclusively predict that FMC will beat the consensus EPS estimate.Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.For the last reported quarter, it was expected that FMC would post earnings of $0.50 per share when it actually produced earnings of $0.63, delivering a surprise of +26%.Over the last four quarters, the company has beaten consensus EPS estimates two times.Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.FMC doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.Expected Results of an Industry PlayerAmong the stocks in the Zacks Chemical - Diversified industry, Dow Inc. (DOW) is soon expected to post earnings of $0.46 per share for the quarter ended September 2024. This estimate indicates a year-over-year change of -4.2%. This quarter's revenue is expected to be $10.73 billion, down 0% from the year-ago quarter.The consensus EPS estimate for Dow Inc. has been revised 8.2% lower over the last 30 days to the current level. However, a lower Most Accurate Estimate has resulted in an Earnings ESP of -0.26%.When combined with a Zacks Rank of #5 (Strong Sell), this Earnings ESP makes it difficult to conclusively predict that Dow Inc. will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.Infrastructure Stock Boom to Sweep AmericaA massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.The only question is “Will you get into the right stocks early when their growth potential is greatest?”Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.Download FREE: How To Profit From Trillions On Spending For Infrastructure >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report FMC Corporation (FMC): Free Stock Analysis Report Dow Inc. (DOW): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf FMC
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf FMC
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Fresenius Medical Care (FMC) St.
Analysen zu Fresenius Medical Care (FMC) St.
Datum | Rating | Analyst | |
---|---|---|---|
18.11.2024 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. | |
15.11.2024 | Fresenius Medical Care (FMC) St Halten | DZ BANK | |
12.11.2024 | Fresenius Medical Care (FMC) St Neutral | UBS AG | |
06.11.2024 | Fresenius Medical Care (FMC) St Hold | Deutsche Bank AG | |
06.11.2024 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Datum | Rating | Analyst | |
---|---|---|---|
18.11.2024 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. | |
06.11.2024 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.11.2024 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.11.2024 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. | |
04.11.2024 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
15.11.2024 | Fresenius Medical Care (FMC) St Halten | DZ BANK | |
12.11.2024 | Fresenius Medical Care (FMC) St Neutral | UBS AG | |
06.11.2024 | Fresenius Medical Care (FMC) St Hold | Deutsche Bank AG | |
06.11.2024 | Fresenius Medical Care (FMC) St Neutral | UBS AG | |
05.11.2024 | Fresenius Medical Care (FMC) St Market-Perform | Bernstein Research |
Datum | Rating | Analyst | |
---|---|---|---|
06.11.2024 | Fresenius Medical Care (FMC) St Underweight | JP Morgan Chase & Co. | |
05.11.2024 | Fresenius Medical Care (FMC) St Sell | Warburg Research | |
05.11.2024 | Fresenius Medical Care (FMC) St Underperform | Jefferies & Company Inc. | |
05.11.2024 | Fresenius Medical Care (FMC) St Underweight | JP Morgan Chase & Co. | |
30.10.2024 | Fresenius Medical Care (FMC) St Underweight | JP Morgan Chase & Co. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen